Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz, Thomas Reiberger, Kerstin Zinober et al.|Scientific Reports|2025Cited by 4
WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertensionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regressionThomas Sorz‐Nechay, Thomas Reiberger, Ines Truebenbach et al.|Journal of Hepatology|2024Cited by 0
FRI-058-YI Time-resolved liver fibrosis regression at single-cell resolution in a murine CCl4-cessation modelKatharina Bonitz, Thomas Reiberger, Thomas Sorz‐Nechay et al.|Journal of Hepatology|2025Cited by 0
THU-486 The anticoagulant Edoxaban improves portal hypertension and liver injury in progressive liver diseaseKatharina Bonitz, Benedikt Hofer, Henriette Horstmeier et al.|Journal of Hepatology|2025Cited by 0